Akero Therapeutics Inc
AKRO54.650USD
0.000
Market hours （ET）Quotes delayed by 15 min
4.38BMarket Cap
LossP/E TTM
Akero Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
--
--
EPS(YoY)
-3.75
-30.05%
Analyst Rating
HOLD
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its total revenue reached --, with a year-on-year change of --.
What is the Earnings Per Share (EPS) of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -3.754, with a year-on-year change of -30.05%.
What is the net income of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its net income was -252.06M, with a year-on-year change of -66.09%.
What is the net margin of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its net profit margin was --, with a year-on-year change of --.
What is the gross margin of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its gross margin was --, with a year-on-year change of --.
What is the debt-to-asset ratio of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was 4.27%, with a year-on-year change of -0.66%.
What is the Return on Equity (ROE) of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -39.22%, with a year-on-year change of -11.36%.
What is the Return on Assets (ROA) of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -35.85%, with a year-on-year change of -10.66%.
What is the operating profit of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its operating profit was -285.42M, with a year-on-year change of -65.11%.
What are the current assets of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its current assets were 770.38M, with a year-on-year change of 37.58%.
What are the total assets of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its total assets of Akero Therapeutics Inc were 825.89M, with a year-on-year change of 42.33%.
What are the total liabilities of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its total liabilities of Akero Therapeutics Inc were 75.77M, with a year-on-year change of 68.52%.
What is the total equity of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its total equity of Akero Therapeutics Inc was 750.11M, with a year-on-year change of 40.13%.
What is the net operating income of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its net operating income of Akero Therapeutics Inc was -252.06M, with a year-on-year change of -66.09%.
What is the net investment of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its net investment of Akero Therapeutics Inc was -109.71M, with a year-on-year change of 50.94%.
What is the net financing of Akero Therapeutics Inc?
According to Akero Therapeutics Inc's FY2024 earnings report, its net financing of Akero Therapeutics Inc was 445.85M, with a year-on-year change of 26.19%.
